• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道癌中的表观遗传重编程:生物学与转化医学视角

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives.

作者信息

Wang Yingjie, Liu Hongyu, Zhang Mengsha, Xu Jing, Zheng Liuxian, Liu Pengpeng, Chen Jingyao, Liu Hongyu, Chen Chong

机构信息

State Key Laboratory of Biotherapy and Cancer Center West China Hospital Sichuan University Chengdu Sichuan China.

出版信息

MedComm (2020). 2024 Aug 24;5(9):e670. doi: 10.1002/mco2.670. eCollection 2024 Sep.

DOI:10.1002/mco2.670
PMID:39184862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11344282/
Abstract

Gastrointestinal tumors, the second leading cause of human mortality, are characterized by their association with inflammation. Currently, progress in the early diagnosis and effective treatment of gastrointestinal tumors is limited. Recent whole-genome analyses have underscored their profound heterogeneity and extensive genetic and epigenetic reprogramming. Epigenetic reprogramming pertains to dynamic and hereditable alterations in epigenetic patterns, devoid of concurrent modifications in the underlying DNA sequence. Common epigenetic modifications encompass DNA methylation, histone modifications, noncoding RNA, RNA modifications, and chromatin remodeling. These modifications possess the potential to invoke or suppress a multitude of genes associated with cancer, thereby governing the establishment of chromatin configurations characterized by diverse levels of accessibility. This intricate interplay assumes a pivotal and indispensable role in governing the commencement and advancement of gastrointestinal cancer. This article focuses on the impact of epigenetic reprogramming in the initiation and progression of gastric cancer, esophageal cancer, and colorectal cancer, as well as other uncommon gastrointestinal tumors. We elucidate the epigenetic landscape of gastrointestinal tumors, encompassing DNA methylation, histone modifications, chromatin remodeling, and their interrelationships. Besides, this review summarizes the potential diagnostic, therapeutic, and prognostic targets in epigenetic reprogramming, with the aim of assisting clinical treatment strategies.

摘要

胃肠道肿瘤是人类死亡的第二大主要原因,其特点是与炎症相关。目前,胃肠道肿瘤的早期诊断和有效治疗进展有限。最近的全基因组分析强调了它们的高度异质性以及广泛的遗传和表观遗传重编程。表观遗传重编程涉及表观遗传模式的动态和可遗传改变,而基础DNA序列没有同时发生改变。常见的表观遗传修饰包括DNA甲基化、组蛋白修饰、非编码RNA、RNA修饰和染色质重塑。这些修饰有可能激活或抑制许多与癌症相关的基因,从而控制具有不同可及性水平的染色质构型的建立。这种复杂的相互作用在胃肠道癌的发生和发展中起着关键且不可或缺的作用。本文重点探讨表观遗传重编程在胃癌、食管癌和结直肠癌以及其他罕见胃肠道肿瘤的发生和发展中的影响。我们阐明了胃肠道肿瘤的表观遗传格局,包括DNA甲基化、组蛋白修饰、染色质重塑及其相互关系。此外,本综述总结了表观遗传重编程中潜在的诊断、治疗和预后靶点,旨在辅助临床治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/151614f93fa2/MCO2-5-e670-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/d81a23570f7c/MCO2-5-e670-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/7df82d8b5b37/MCO2-5-e670-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/83d1cefedda6/MCO2-5-e670-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/151614f93fa2/MCO2-5-e670-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/d81a23570f7c/MCO2-5-e670-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/7df82d8b5b37/MCO2-5-e670-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/83d1cefedda6/MCO2-5-e670-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cfd/11344282/151614f93fa2/MCO2-5-e670-g005.jpg

相似文献

1
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives.胃肠道癌中的表观遗传重编程:生物学与转化医学视角
MedComm (2020). 2024 Aug 24;5(9):e670. doi: 10.1002/mco2.670. eCollection 2024 Sep.
2
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
3
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone.系统综述肾脏疾病中的表观遗传相互作用:长非编码 RNA 与染色质甲基化、乙酰化和组蛋白之间的串扰。
Biomed Pharmacother. 2024 Jul;176:116922. doi: 10.1016/j.biopha.2024.116922. Epub 2024 Jun 12.
4
Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification.非编码RNA与胃癌表观遗传修饰的相互作用:聚焦于组蛋白修饰
Front Oncol. 2022 Jan 26;11:822745. doi: 10.3389/fonc.2021.822745. eCollection 2021.
5
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance.表观遗传修饰:癌症异质性和耐药性的关键因素
Transl Oncol. 2024 Jan;39:101821. doi: 10.1016/j.tranon.2023.101821. Epub 2023 Nov 4.
6
Connections between metabolism and epigenetic modifications in cancer.癌症中代谢与表观遗传修饰之间的联系。
Med Rev (2021). 2022 Feb 14;1(2):199-221. doi: 10.1515/mr-2021-0015. eCollection 2021 Dec.
7
Epigenetic therapy in gastrointestinal cancer: the right combination.胃肠道癌症的表观遗传治疗:正确的组合
Therap Adv Gastroenterol. 2016 Jul;9(4):560-79. doi: 10.1177/1756283X16644247. Epub 2016 May 1.
8
Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.揭示结直肠癌的遗传和表观遗传景观:对发病机制途径的新认识。
Med Oncol. 2023 Oct 19;40(11):334. doi: 10.1007/s12032-023-02201-8.
9
Gene methylation in gastric cancer.胃癌中的基因甲基化。
Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10.
10
Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.胃肠道中的表观遗传改变:癌症生物标志物的当前和新兴用途。
Adv Cancer Res. 2021;151:425-468. doi: 10.1016/bs.acr.2021.02.006. Epub 2021 Mar 18.

引用本文的文献

1
AMBRA1 drives gastric cancer progression through regulation of tumor plasticity.AMBRA1通过调节肿瘤可塑性驱动胃癌进展。
Front Immunol. 2024 Dec 10;15:1494364. doi: 10.3389/fimmu.2024.1494364. eCollection 2024.

本文引用的文献

1
Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer.ASCL1/ZNF582 甲基化检测在高级别肛门上皮内瘤变和肛门癌检测中的分析验证和诊断性能。
Tumour Virus Res. 2024 Jun;17:200275. doi: 10.1016/j.tvr.2023.200275. Epub 2023 Dec 30.
2
Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer.磷脂酰乙醇胺结合蛋白 1 下调与胆囊癌临床意义的相关性研究。
Dig Dis Sci. 2024 Feb;69(2):502-509. doi: 10.1007/s10620-023-08216-5. Epub 2023 Dec 22.
3
Blood DNA methylation and liver cancer in American Indians: evidence from the Strong Heart Study.
美国印第安人血液 DNA 甲基化与肝癌:来自“强壮心脏研究”的证据。
Cancer Causes Control. 2024 Apr;35(4):661-669. doi: 10.1007/s10552-023-01822-8. Epub 2023 Nov 27.
4
Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation.数据挖掘表明,结肠癌中 CXCL14 基因沉默是由于启动子甲基化。
Int J Mol Sci. 2023 Nov 7;24(22):16027. doi: 10.3390/ijms242216027.
5
Lactate as a major epigenetic carbon source for histone acetylation via nuclear LDH metabolism.通过核 LDH 代谢,乳酸作为组蛋白乙酰化的主要表观遗传碳源。
Exp Mol Med. 2023 Oct;55(10):2238-2247. doi: 10.1038/s12276-023-01095-w. Epub 2023 Oct 2.
6
GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway.GPR37 通过激活 Hippo 通路促进糖酵解和组蛋白乳酰化作用从而促进结直肠癌肝转移。
Oncogene. 2023 Nov;42(45):3319-3330. doi: 10.1038/s41388-023-02841-0. Epub 2023 Sep 25.
7
SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle.SETDB1 通过增强乳酸穿梭促进肿瘤进展来甲基化 MCT1。
Adv Sci (Weinh). 2023 Oct;10(28):e2301871. doi: 10.1002/advs.202301871. Epub 2023 Aug 4.
8
Cancers make their own luck: theories of cancer origins.癌症创造自己的运气:癌症起源理论。
Nat Rev Cancer. 2023 Oct;23(10):710-724. doi: 10.1038/s41568-023-00602-5. Epub 2023 Jul 24.
9
Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger.55 岁及以下 MLH1 甲基化的错配修复缺陷型结直肠癌患者中,MLH1 甲基化主要源于宪法性改变。
J Natl Compr Canc Netw. 2023 Jul;21(7):743-752.e11. doi: 10.6004/jnccn.2023.7020.
10
Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches.针对食管癌的表观遗传失调进行靶向治疗:最新进展和新兴方法。
Cell Biol Toxicol. 2023 Dec;39(6):2437-2465. doi: 10.1007/s10565-023-09818-5. Epub 2023 Jun 20.